4 unknown. 4 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Unknown 4 |
| Phase 2 | 2 | Unknown 2 |
Follow Nephrosis: new trials by email Literature Review of Nephrosis trials Research Report on Nephrosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy of Rituximab in Comparison to Continued Corticosteroid Treatment in Idiopathic Nephrotic Syndrome Rituximab, Prednisone - Idiopathic Nephrotic Syndrome, Minimal Change Disease | Phase 3 | Unknown | Radboud University Medical Center | 40 | 2018-08-22 | 2018-08-27 |
| Valproic Acid for Idiopathic Nephrotic Syndrome Valproic Acid - Idiopathic Nephrotic Syndrome, Focal Segmental Glomerulosclerosis | Phase 2 / Phase 3 | Unknown | Universitair Ziekenhuis Brussel | 15 | 2016-10-01 | 2017-06-20 |
| Rituximab Trial for Pediatric Nephrotic Syndrome Rituximab, Placebo - Steroid Resistant Nephrotic Syndrome, Steroid Dependent Nephrotic Syndrome | Phase 2 / Phase 3 | Unknown | Seoul National University Childrens Hospital | 88 | 2012-08-01 | 2012-10-29 |
| Lymphocyte Markers As Predictors Of Responsiveness To Rituximab Among Patients With Idiopathic Nephrotic Syndrome Rituximab - Nephrotic Syndrome | Phase 3 | Unknown | National University Health System, Singapore | 100 | 2008-06-01 | 2019-08-28 |
Glomerulosclerosis, Focal Segmental (2) · Nephrosis, Lipoid (2) · Nephrotic Syndrome (2)
Female Urogenital Diseases (4) · Female Urogenital Diseases and Pregnancy Complications (4) · Kidney Diseases (4) · Male Urogenital Diseases (4) · Urogenital Diseases (4) · Urologic Diseases (4) · Glomerulonephritis (2) · Nephritis (2)
Rituximab (3) · Prednisolone (1) · Prednisone (1) · Valproic Acid (1)
National University Health System, Singapore (1) · Radboud University Medical Center (1) · Seoul National University Childrens Hospital (1) · Universitair Ziekenhuis Brussel (1)
Belgium (1) · Netherlands (1) · Singapore (1) · South Korea (1)
Jack F Wetzels, MD, PhD (1) · Jeroen K Deegens, MD,PhD (1) · Peter Janssens, MD (1)